Last updated: 26 September 2023 at 4:33pm EST

William Rose Net Worth




The estimated Net Worth of William Rose is at least 4.14 百万$ dollars as of 15 July 2005. Mr. Rose owns over 20,666 units of Reata Pharmaceuticals Inc stock worth over 3,561,992$ and over the last 21 years he sold RETA stock worth over 0$. In addition, he makes 574,629$ as Independent Director at Reata Pharmaceuticals Inc.

Mr. Rose RETA stock SEC Form 4 insiders trading

William has made over 2 trades of the Reata Pharmaceuticals Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 20,666 units of RETA stock worth 158,715$ on 15 July 2005.

The largest trade he's ever made was exercising 20,666 units of Reata Pharmaceuticals Inc stock on 15 July 2005 worth over 158,715$. On average, William trades about 1,307 units every 1 days since 2003. As of 15 July 2005 he still owns at least 20,666 units of Reata Pharmaceuticals Inc stock.

You can see the complete history of Mr. Rose stock trades at the bottom of the page.





William Rose biography

William E. Rose serves as Independent Director of the Company. Prior to Montrose, Mr. Rose was associated with HBK Capital Management from 1991 until 2012, serving in various capacities, including Co-Chief Investment Officer. He currently serves on the Board of Greenhill School and is also a member of the Investment Committee for the Dallas Museum of Art. Mr. Rose received a B.A. in Political Science from Duke University in 1989. Our Board believes that Mr. Rose is qualified to serve on our Board due to his extensive experience investing, his experience with venture capital investments and his board service for other enterprises.

What is the salary of William Rose?

As the Independent Director of Reata Pharmaceuticals Inc, the total compensation of William Rose at Reata Pharmaceuticals Inc is 574,629$. There are 12 executives at Reata Pharmaceuticals Inc getting paid more, with Manmeet Soni having the highest compensation of 12,612,200$.



How old is William Rose?

William Rose is 51, he's been the Independent Director of Reata Pharmaceuticals Inc since 2016. There are 7 older and 8 younger executives at Reata Pharmaceuticals Inc. The oldest executive at Reata Pharmaceuticals Inc is Michael D. Wortley, 73, who is the Exec. VP & Chief Legal Officer.

What's William Rose's mailing address?

William's mailing address filed with the SEC is 4215 WEST LOVERS LANE, SUITE 200, , DALLAS, TX, 75209.

Insiders trading at Reata Pharmaceuticals Inc

Over the last 8 years, insiders at Reata Pharmaceuticals Inc have traded over 176,850,875$ worth of Reata Pharmaceuticals Inc stock and bought 8,443,489 units worth 179,313,590$ . The most active insiders traders include Holdings A/S NovoR Kent Jr Mc GaughyInc Cpmg. On average, Reata Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of 10,950,893$. The most recent stock trade was executed by Andrea Loewen on 14 September 2023, trading 3,175 units of RETA stock currently worth 546,195$.



What does Reata Pharmaceuticals Inc do?

reata pharmaceuticals, inc. (nasdaq:reta) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.



What does Reata Pharmaceuticals Inc's logo look like?

Reata Pharmaceuticals Inc logo

Complete history of Mr. Rose stock trades at Reata Pharmaceuticals Inc、Impac Mortgage

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
15 Jul 2005 William Rose
ディレクター
オプション行使 20,666 7.68$ 158,715$
15 Jul 2005
20,666
23 Jun 2005 William Rose
ディレクター
オプション行使 4,166 7.68$ 31,995$
23 Jun 2005
4,166


Reata Pharmaceuticals Inc executives and stock owners

Reata Pharmaceuticals Inc executives and other stock owners filed with the SEC include: